Found: 4
Select item for more details and to access through your institution.
Ribociclib-Induced Cutaneous Adverse Events in Metastatic HR+/HER2− Breast Cancer: Incidence, Multidisciplinary Management, and Prognostic Implication.
- Published in:
- Oncologist, 2024, v. 29, n. 6, p. 484, doi. 10.1093/oncolo/oyae004
- By:
- Publication type:
- Article
Sticking to the Rules: Outcome and Success Rate of Guideline-Based Diarrhea Management in Metastatic Breast Cancer Patients Treated with Abemaciclib.
- Published in:
- Journal of Clinical Medicine, 2023, v. 12, n. 5, p. 1775, doi. 10.3390/jcm12051775
- By:
- Publication type:
- Article
A Case of Pulmonary Sarcoidosis during First-Line Targeted Therapy with Dabrafenib Plus Trametinib in BRAF V600E-Mutated Metastatic Melanoma.
- Published in:
- 2022
- By:
- Publication type:
- Case Study
Tailored Toxicity-Driven Administration of Vismodegib in Patients With Multiple or Locally Advanced Basal Cell Carcinoma: A Pilot Analysis.
- Published in:
- Frontiers in Oncology, 2020, v. 11, p. N.PAG, doi. 10.3389/fonc.2020.563404
- By:
- Publication type:
- Article